| 178 | 16 | 62 |
| 下载次数 | 被引频次 | 阅读次数 |
目的分析炔雌醇环丙孕酮片联用二甲双胍对多囊卵巢综合征(PCOS)患者激素水平的影响,为其提供循证医学证据。方法从Pub Med、Cochrane、CBM、CNKI获得炔雌醇环丙孕酮片联用二甲双胍及单用炔雌醇环丙孕酮片治疗PCOS的随机对照试验(RCTs)文献,使用"Rev Man 5.3"软件进行分析,以评估炔雌醇环丙孕酮片联用二甲双胍及单用炔雌醇环丙孕酮片对PCOS患者激素水平的影响。结果文献检索共纳入24项随机对照试验,包括1 548例PCOS患者,其中对照组775例,试验组773例。Meta分析结果显示,与单用炔雌醇环丙孕酮片相比,炔雌醇环丙孕酮片协同二甲双胍对于改善患者卵泡刺激素(MD=-0.49,95%CI[-1.11,0.13],Z=1.54,P=0.12)和脱氢表雄酮(MD=0.07,95%CI[-0.24,0.38],Z=0.43,P=0.67)的疗效并不显著;改善患者黄体生成素(MD=-1.24,95%CI[-2.09,-0.39],Z=2.87,P=0.004)效果明显;改善患者性激素结合球蛋白(MD=28.22,95%CI[7.78,48.66],Z=2.71,P=0.007)效果差。结论炔雌醇环丙孕酮片协同二甲双胍可明显改善患者黄体生成素水平,对于单纯改善PCOS患者体内卵泡刺激素和脱氢表雄酮水平上并不显著。
Abstract：AIM To analyze the effect of progesterone on the hormone levels in patients with polycystic ovary syndrome( PCOS),and to provide evidence-based medicine. METHODS A randomized controlled trial( RCT) of PCOS was obtained from Pub Med,Cochrane,CBM and CNKI in the treatment of PCOS with ethinylestradiol cyproterone tablets combined with metformin and ethinylestradiol alone. The " Rev Man 5. 3 " software was used to estimate the effect of ethinylestradiol cyproterone tablets combined with metformin and ethinylestradiol cyproterone tablets alone on the level of hormone in PCOS patients. RESULTS A total of 24 randomized controlled trials were incorporated into the literature search,including 1 548 patients with PCOS,of which 775 were in the control group and 773 in the trial group. Meta-analysis showed that ethinylestradiol cyproterone tablets combined with metformin were not effective in improving follicle-stimulating hormone level( MD =-0. 49,95 %CI[-1. 11,0. 13 ],Z = 1. 54,P = 0. 12) and dehydroepiandrosterone( MD = 0. 07,95 % CI[-0. 24,0. 38 ],Z = 0. 43,P = 0. 67) level in patients compared with ethinylestradiol cyproterone alone in patients. The ethinylestradiol cyproterone tablets combined with metformin were effective in improving luteinizing hormone level( MD=-1. 24,95% CI[-2. 09,-0. 39 ],Z = 2. 87,P = 0. 004) in patients compared with ethinylestradiol cyproterone alone in patients. The ethinylestradiol cyproterone tablets combined with metformin were less effective in improving sex hormone binding globulin level( MD = 28. 22,95% CI[7. 78,48. 66 ],Z = 2. 71,P = 0. 007) in patients compared with ethinylestradiol cyproterone alone in patients. CONCLUSION Ethinylestradiol cyproterone tablets combined with metformin can significantly improve the level of luteinizing hormone in patients,and it is not significant for the simple improvement of follicle stimulating hormone and dehydroepiandrosterone in PCOS patients.
[1]李昱川.多囊卵巢综合征患者脂代谢紊乱与体重、胰岛素抵抗和雄激素水平的关系[J].中国妇幼保健,2014,29(03):354.
[2]张彩宇,陶爱群,莫有珍.二甲双胍与炔雌醇环丙孕酮片联用对多囊卵巢综合征患者相关激素分泌水平的影响[J].中国现代医学杂志,2016,26(09):85.
[3]杨昱,刘超.2013年美国内分泌学会多囊卵巢综合征诊疗指南解读[J].中华内分泌代谢杂志,2014,30(2):89
[4]SANKE S,CHANDER R,JAIN A,et al.A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women[J].JAMA Dermatology,2016,152(9):986.
[5]MHAO NS,AL-HILLI ASA,HADI NR,et al.A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome[J].Diabetes Metab Res Rev,2016,10(1):S95.
[6]ZHANG J,XU LZ,WU TX,et al.The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome:An updated systematic review[J].Gynecol Endocrinol,2009,24(10):590.
[7]YANG YM,CHOI EJ.Efficacy and safety of metformin or oral contraceptives,or both in polycystic ovary syndrome[J].Ther Clin Risk Manag,2015,11(1),1345.
[8]ELTER K,IMIR G,DURMUSOGLU F.Clinical,endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study[J].Hum Reprod,2002,17(7):1729.
[9]LV LQ,LIU Y,SUN YY,TAN K.Effects of metformin combined with cyproterone acetate on clinical features,endocrine and metabolism of non-obese women with polycystic ovarian syndrome[J].J Huazhong Univ Sci Technolog Med Sci,2005,25(2):194.
[10]FENG W,JIA YY,ZHANG DY,et al.Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin[J].Gynecol Endocrinol,2016,32(2):147.
[11]夏彦.炔雌醇环丙孕酮片联合二甲双胍对PCOS患者内分泌的影响[J].当代医学,2011,17(27):146.
[12]孙文霞,李锐,韩丽娟.二甲双胍片结合达英-35治疗多囊卵巢综合症的疗效研究[J].实用妇科内分泌电子杂志,2015,2(05):117.
[13]张爱玉,孙妙婷.炔雌醇环丙孕酮联合二甲双胍治疗多囊卵巢综合征52例临床观察[J].赣南医学院学报,2014,36(06):861.
[14]方烨.二甲双胍联合醋酸环丙孕酮治疗多囊卵巢综合征患者血清25羟维生素D及胰岛素抵抗的变化[D].长沙:中南大学,2012.
[15]李俊.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征临床效果探讨[J].中外医疗,2016,35(4):37.
[16]杨志平.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征对激素、胰岛素抵抗的影响[J].中国妇幼保健,2016,31(5):1015.
[17]梁金艳.达英联合二甲双胍治疗PCOS的临床疗效[J].中国性科学,2012,21(7):42.
[18]武红琴,阮祥燕,卢永军,等.综合管理下炔雌醇环丙孕酮片与炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征的疗效研究[J].首都医科大学学报,2014(04):407.
[19]王娟.复方醋酸环丙孕酮联合二甲双胍治疗多囊卵巢综合征的疗效及对内分泌代谢的影响[J].检验医学与临床,2014(12):1650.
[20]王桂霞,荣晓云,李建生.80例炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征的临床效果评价[J].世界最新医学信息文摘,2015(35):49.
[21]裴慧琳.炔雌醇环丙孕酮片和二甲双胍对多囊卵巢综合征患者性激素水平及胰岛素抵抗的影响[J].中国医药导报,2013(01):73.
[22]金海鸿,张宇杰,孙颖,等.炔雌醇环丙孕酮片联合二甲双胍治疗肥胖型多囊卵巢综合征的临床研究[J].中国现代医生,2016(05):60.
[23]钦永彩.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合症内分泌代谢紊乱研究[J].临床合理用药杂志,2015(8):63.
[24]陈志敏,史惠蓉,任芳,等.炔雌醇环丙孕酮片联合二甲双胍治疗伴胰岛素抵抗型多囊卵巢综合征疗效观察[J].中国妇幼保健,2012,27(6):934.
[25]霍琰,曹丽君,田丽.二甲双胍、炔雌醇环丙孕酮片对PCOS患者内分泌的影响[J].中国妇幼保健,2008(12):1704.
[26]马加兰.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征的临床疗效及对内分泌的影响[J].中国医药指南,2015(26):137.
[27]黄涛,罗业琳,曾祥娥.达英-35联合二甲双胍治疗多囊卵巢综合征56例及对妊娠分娩结局的影响[J].中国药业,2015(19):29.
[28]叶碧绿,杨海燕,赵军招,等.二甲双胍与复方醋酸环丙孕酮联合应用对多囊卵巢综合征患者内分泌及代谢的影响[J].中华妇产科杂志,2003,38(12):745.
[29]肖青,郭勇,刘妍.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征临床效果观察[J].中国优生与遗传杂志,2010(03):89.
[30]WU J,ZHU Y,JIANG Y,et al.Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical,endocrine and metabolic factors in women with polycystic ovary syndrome[J].Gynecol Endocrinol,2008,24(7):392.
[31]史樱,金婧.炔雌醇环丙孕酮片联合二甲双胍治疗多囊卵巢综合征的疗效观察[J].中国妇幼保健,2007(24):3449.
[32]de LEO V,MUSACCHIO MC,CAPPELLI V,et al.Genetic,hormonal and metabolic aspects of PCOS:an update[J].Reprod Biol Endocrinol,2016,14(1):38.
[33]KUMAR AN,NAIDU JN,SATYANARAYANA LL,et al.Metabolic and endocrine characteristics of Indian women with polycystic ovary syndrom[J].Int J Fertili Steril,2016,10(1):22.
[34]Huang-TzOU,CHEN PC,WU MH,et al.Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome[J].Health Qual Life Outcomes,2016,14(1):119.
[35]DUMITRESCU R,MEHEDINTU C,BRICEAG I,et al.Metformin-clinical pharmacology in PCOs.[J].J Med Life,2015,8(2):187.
[36]CETINKALP S,KARADENIZ M,ERDOGAN M,et al.The effects of rosiglitazone,metformin,and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome[J].Endocrinologist,2009,19(3):94.
[37]COSTELLO M,SHRESTHA B,EDEN J,et al.Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism,acne and risk of diabetes,cardiovascular disease,and endometrial cancer in polycystic ovary syndrome[J].Cochrane Database Syst Rev,2007(1):CD005552.
基本信息:
中图分类号:R711.75
引用信息:
[1]陈金曼,夏承来,杨洁,等.炔雌醇环丙孕酮片协同二甲双胍对多囊卵巢综合征患者激素水平影响的Meta分析[J].中国临床药学杂志,2017,26(05):308-314.
基金信息:
广东省科技计划项目(粤科规财字[2014]116号2013B021800188)
2017-09-25
2017-09-25